U2OS-CRISPR-NUP96-Halo Cells
CAD$1,104.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The U-2 OS-CRISPR-NUP96-Halo is a genetically engineered cell line derived from the human osteosarcoma U-2 OS cells. This cell line has been modified using CRISPR-Cas9 technology to incorporate a HaloTag at the NUP96 gene locus. NUP96, part of the nuclear pore complex, plays a critical role in nuclear transport and cellular regulation. The introduction of the HaloTag allows for the precise visualization and biochemical characterization of NUP96's dynamics and interactions within the cell. By facilitating the covalent attachment of fluorescent ligands or other probes, the HaloTag enables real-time imaging and provides a powerful tool for studying the nuclear transport mechanisms in living cells. This particular clone, number 252, has been selected for its stable expression of the HaloTagged NUP96, ensuring consistent performance in experimental setups. This feature makes it highly suitable for high-resolution imaging techniques and molecular interaction studies, thereby supporting advanced research in cellular biology, particularly in the context of nuclear function and genetic regulation. |
|---|---|
| Organism | Human |
| Tissue | Bone |
| Disease | Osteosarcoma |
Characteristics
| Age | 15 years |
|---|---|
| Gender | Female |
| Ethnicity | Caucasian |
| Morphology | Epithelial-like |
| Growth properties | Adherent |
Regulatory Data
| Citation | U-2 OS-CRISPR-NUP96-Halo (Cytion catalog number 300448) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_B7FI |
| Depositor | The Ellenberg Lab (EMBL) |
| GMO Status | GMO-S1: This human osteosarcoma cell line (U2OS-CRISPR-NUP96-Halo, clone 252) contains a CRISPR-edited NUP96-Halo fusion generated via lentiviral delivery, enabling fluorescent labeling of nuclear pore complexes. The modification is stably integrated. This classification applies only within Germany and may differ elsewhere. |
Biomolecular Data
| Protein expression | NUP96-Halo (endogenous nuclear pore complex protein 96, Halo tagged) |
|---|
Handling
| Culture Medium | McCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 1 x 104 cells/cm2 |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300448-311024 | Certificate of Analysis | 26. May. 2025 | 300448 |
| 300448-221 | Certificate of Analysis | 23. May. 2025 | 300448 |
| 300448-221 | Certificate of Analysis | 26. May. 2025 | 300448 |
| 300448-221 | Certificate of Analysis | 23. May. 2025 | 300448 |
-
Related products
Related products